c-LEcta [Germany] is a fully integrated industrial biotechnology company located in Leipzig, Germany. The company currently employs about 50 people and has established itself as leading player in the realization of high-value biotech products for regulated markets, either as in-house developments or in close cooperation with the industry. c-LEcta delivers cost-efficient and sustainable production processes which enable to open new and to better penetrate existing markets.
ViroVet [Belgium] is a biopharmaceutical company with a clear objective to develop innovative technologies to improve the health and value of livestock. The company is headquartered in Heverlee near Leuven, Belgium and continues to build on the livestock assets and know-how that it has accumulated since 2008 while adding new products, including vaccines, to the pipeline.
DMC [USA] is leading the low cost sustainable transformation of multiple product markets. Its novel, patent-pending technology for rapid engineering of robust microbial hosts enables the production of a broad diversity of specialty chemicals, flavours, fragrances, nutraceuticals, natural products, pharmaceuticals, and APIs.